
Analgesics in South Korea
Description
Analgesics in South Korea
Analgesics is set to maintain solid retail current value growth in South Korea in 2024. Paediatric analgesics, especially paediatric ibuprofen, is expected to see the strongest growth, followed by adult Ibuprofen, with increases in the double digits. Consumers’ purchasing patterns have become more sophisticated, particularly during the influenza season, when many outlets face stock shortages. Liquid formats of paediatric acetaminophen sell better than tablet formats. However, during these times,...
Euromonitor International's Analgesics in South Korea report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
29 Pages
- Analgesics in South Korea
- Euromonitor International
- September 2024
- List Of Contents And Tables
- ANALGESICS IN SOUTH KOREA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Consumers experience frequent supply shortages, driving growth in paediatric analgesics
- Surge in influenza cases boosts sales of analgesics
- Topical analgesics/anaesthetic sees slight value growth, with support from format development and the specific positioning for golf and tennis
- PROSPECTS AND OPPORTUNITIES
- Sales of analgesics through convenience stores not likely to see as rapid growth as the government expects, due to high healthcare accessibility
- Quality standards expected to become a more important factor
- Platform delivery services likely to take time to expand in South Korea
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2019-2024
- Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
- Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
- Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
- Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
- CONSUMER HEALTH IN SOUTH KOREA
- EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 8 Life Expectancy at Birth 2019-2024
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2019-2024
- Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
- Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.